April 4 (Reuters) - The Centers for Medicare & Medicaid
Services said on Friday that it did not move forward with a
proposal put forth by the Biden administration on Medicare
coverage of weight-loss drugs such as Novo Nordisk's
Wegovy.
(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini
Ganguli)